Journal of Medicinal Chemistry · 2011 · 136 citations · 38 references
MedicineMedicinal ChemistryPharmacologyApoptosisCancer PharmacologyDrug DiscoveryChemotherapy ResistanceCytotoxic ChemotherapyMicrotubule-associated ProteinsMicrotubule-targeting AgentsAnticancer ActivityAntimitotic ActivityAntimitotic DrugsAntiproliferative AgentsAntiproliferative Drug ActionColchicine Site BindingPalladium-catalyzed Cross-couplingTubulin Polymerization Inhibitors
Tubulin, the major structural component of microtubules, is a target for the development of anticancer agents. Two series of 1,5-diaryl substituted 1,2,3,4-tetrazoles were concisely synthesized, using a palladium-catalyzed cross-coupling reaction, and identified as potent antiproliferative agents and novel tubulin polymerization inhibitors that act at the colchicine site. SAR analysis indicated that compounds with a 4-ethoxyphenyl group at the N-1 or C-5 position of the 1,2,3,4-tetrazole ring exhibited maximal activity. Several of these compounds also had potent activity in inhibiting the growth of multidrug resistant cells overexpressing P-glycoprotein. Active compounds induced apoptosis through the mitochondrial pathway with activation of caspase-9 and caspase-3. Furthermore, compound 4l significantly reduced in vivo the growth of the HT-29 xenograft in a nude mouse model, suggesting that 4l is a promising new antimitotic agent with clinical potential.
38
I. Vermes, C. Haanen, H M Steffens-Nakken et al. · Journal of Immunological Methods · 1995 · 5.4K citations · Full text
Stefano De Cillà, Serena Farruggio, Stela Vujosevic et al. · Cellular Physiology and Biochemistry · 2017 · 5.1K citations · Full text
The Pathophysiology of Mitochondrial Cell Death
Douglas R. Green, Guido Kroemer · Science · 2004 · 3.4K citations